Not a good buy right now for an impatient buyer: price is extended (RSI ~81 overbought) and is trading right into resistance (around R1 ~$93.08 / near R2 ~$94.30), which skews near-term odds toward a pullback.
Trend is still constructive (MACD histogram positive and expanding), but without any Intellectia buy signals today and with hedge funds heavily net selling, the risk/reward at this exact level looks unfavorable.
If you already own it, this is more of a hold than an add; if you don’t, the better entry is likely on a dip back toward the pivot/support zone (~$91.11).
Technical Analysis
Price/levels: Pre-market ~$93.40, above pivot ~$91.11 and pressing resistance R1 ~$93.08; next resistance R2 ~$94.30; support S1 ~$89.15.
Momentum: MACD histogram 0.4 (above zero and expanding) = bullish momentum remains in place.
Overbought condition: RSI(6) ~80.96 = overbought, raising probability of near-term mean reversion.
Moving averages: “Converging” MAs suggest consolidation/late-stage move rather than a fresh breakout impulse.
Pattern-based bias: Similar-pattern stats imply ~60% chance of ~-0.53% next day (near-term soft), with modestly positive 1-month expectation (+1.73%).
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Open interest put-call ratio 0.12 = extremely call-heavy positioning (bullish skew).
Flow: Put-call volume ratio 0.64 = calls leading, but not euphoric; total volume is elevated (today vs 30D avg ~174%), signaling increased attention.
Volatility: IV30 ~22.72 vs HV ~22.26 (roughly aligned); IV percentile ~58 suggests options are not especially cheap or extremely expensive.
Takeaway: Options sentiment leans bullish, but the stock’s overbought technical state increases the chance that bullish positioning is late-cycle rather than early-cycle.
Technical Summary
Sell
5
Buy
11
Positive Catalysts
Technical momentum still positive (MACD expanding above zero).
Options market skew is decisively bullish (very low OI put-call ratio; elevated activity).
Latest quarter financial snapshot was not available from the provided data (cannot assess the most recent quarter/season growth trends from this feed).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent changes: Deutsche Bank raised targets (to $114 from $110; previously also raised in Nov 2025) and maintains Buy.
Barclays raised target to $101 from $99 and maintains Overweight, but notes the recent run may be more “flight to safety” than improving fundamentals; flags potential oil/currency headwinds in 2026.
Citi trimmed its target (to EUR 87 from EUR 90) while keeping Buy.
Wall Street pros vs cons: Pros—ratings remain Buy/Overweight with higher targets from DB/Barclays. Cons—fundamental caution and macro headwinds (oil/currency), plus mixed target direction (Citi cut) and institutional selling pressure.
Politicians/influential trading: No recent congress trading data available in the last 90 days; insiders are neutral (no significant recent insider trend).
Wall Street analysts forecast CCEP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCEP is 99.92 USD with a low forecast of 85.96 USD and a high forecast of 114 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast CCEP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCEP is 99.92 USD with a low forecast of 85.96 USD and a high forecast of 114 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
0 Hold
1 Sell
Strong Buy
Current: 95.920
Low
85.96
Averages
99.92
High
114
Current: 95.920
Low
85.96
Averages
99.92
High
114
Barclays
Overweight
maintain
$99 -> $101
AI Analysis
2026-01-16
Reason
Barclays
Price Target
$99 -> $101
AI Analysis
2026-01-16
maintain
Overweight
Reason
Barclays raised the firm's price target on Coca-Cola Europacific Partners to $101 from $99 and keeps an Overweight rating on the shares. The firm adjusted targets in the consumer staples group as part of a Q4 earnings preview. Barclays attributes the recent "enthusiasm" in the stock to "a flight to safety" and remains concerned about company- and sector-level fundamentals. Potential oil and currency headwinds could materialize in 2026, the analyst tells investors in a research note.
Citi
Simon Hales
Buy
downgrade
2026-01-09
Reason
Citi
Simon Hales
Price Target
2026-01-09
downgrade
Buy
Reason
Citi analyst Simon Hales lowered the firm's price target on Coca-Cola Europacific Partners to EUR 87 from EUR 90 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CCEP
